Gotham Asset Management LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,607 shares of the medical equipment provider's stock after acquiring an additional 1,985 shares during the period. Gotham Asset Management LLC's holdings in Intuitive Surgical were worth $13,366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in the business. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. Finally, BankPlus Trust Department purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Insider Buying and Selling
In other news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on ISRG. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Finally, Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.
View Our Latest Report on Intuitive Surgical
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG opened at $536.55 on Friday. The firm has a market cap of $192.31 billion, a PE ratio of 83.71, a PEG ratio of 5.85 and a beta of 1.70. The firm has a fifty day moving average of $500.93 and a 200 day moving average of $534.86. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the previous year, the firm posted $1.50 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.